New guideline for Helicobacter pylori includes change to primary treatment recommendation

Immunohistochemical_detection_of_Helicobacter_pylori_histopathology

Source: KGH

New guidelines on the treatment of Helicobacter pylori (H. pylori) infection warn against prescribing PPI triple therapy, instead advising practitioners to use bismuth quadruple therapy or one of the other suggested treatment options.

 Registered users, subscribers or members - SIGN IN

To continue reading this article

Membership

Included as a benefit

Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.

I AM A MEMBER

Find out more about how to join.

 

Register

FREE

Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.

REGISTER

 

Subscribe

3.75 per month / £35 annually

Get unlimited access to The Microbiologist.

SUBSCRIBE